Jorge A. Marrero

Gastroenterology

3400 Civic Center Boulevard
South Pavilion, 4th Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 135 publications

Longitudinal Assessment of Clinical Risk Scores for Hepatocellular Carcinoma in Patients With Cirrhosis.

Longitudinal Assessment of Clinical Risk Scores for Hepatocellular Carcinoma in Patients With Cirrhosis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 30, 2026

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.

Journal: Gastroenterology

Published: November 18, 2025

Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis.

Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis.

Journal: Hepatology communications

Published: September 26, 2025

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study.

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 24, 2025

Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance.

Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance.

Journal: Gastro hep advances

Published: June 30, 2025

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort.

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort.

Journal: Journal of hepatology

Published: February 24, 2025

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.

Journal: Hepatology (Baltimore, Md.)

Published: November 26, 2024

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Journal: Hepatology (Baltimore, Md.)

Published: October 26, 2024

Temporal Changes in Risk Factors of Hepatocellular Carcinoma in a Prospective Cirrhosis Cohort.

Temporal Changes in Risk Factors of Hepatocellular Carcinoma in a Prospective Cirrhosis Cohort.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 24, 2024

Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis.

Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis.

Journal: Gastroenterology

Published: August 04, 2024

National Liver Cancer Screening Trial (TRACER) study protocol.

National Liver Cancer Screening Trial (TRACER) study protocol.

Journal: Hepatology communications

Published: August 03, 2024

Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis.

Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis.

Journal: Hepatology communications

Published: June 24, 2024

Showing 1-12 of 135

Last Updated: 09/26/2026